Home
Alerts
Search
Watchlist
Products
Accretion Nutraveda Ltd
ANL
BSE
₹ 267.50
0.52%
Last Updated:
30 Apr '26, 4:00 PM
Industry:
Pharma - Formulators
Accretion Nutraveda Ltd
ANL
BSE
₹ 267.50
0.52%
30 Apr '26, 4:00 PM
Industry
Pharma - Formulators
6M
Price
Charts
Documents
Quick Ratios
Edit Ratios
Mkt Cap
Market Capitalization
₹194Cr
Close
Close Price
₹267.50
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
PS
Price To Sales
12.10
Revenue
Revenue
₹16Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
Peer Comparison
How does ANL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
ANL
VS
Quarterly Results
Standalone
Numbers
Percentage
| Quarter | Sep 2025 |
|---|---|
| 14 | |
Growth YoY Revenue Growth YoY% | |
| 11 | |
| 3 | |
OPM OPM% | 23.5 |
| 0 | |
Interest Expense Interest ExpenseCr | 0 |
Depreciation DepreciationCr | 0 |
PBT PBTCr | 3 |
| 1 | |
| 2 | |
Growth YoY PAT Growth YoY% | |
NPM NPM% | 16.6 |
| 0.0 |
Profit & Loss
Standalone
Numbers
Percentage
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
Revenue RevenueCr | 3 | 5 | 16 |
Growth Revenue Growth% | 72.4 | 219.7 | |
| 2 | 4 | 12 | |
| 1 | 1 | 4 | |
OPM OPM% | 21.4 | 24.4 | 23.3 |
| 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 |
PBT PBTCr | 0 | 1 | 3 |
| 0 | 0 | 1 | |
PAT PATCr | 0 | 1 | 3 |
Growth PAT Growth% | 192.9 | 217.9 | |
NPM NPM% | 9.7 | 16.4 | 16.3 |
| 7.8 | 22.8 | 71.9 |
Balance Sheet
Standalone
Numbers
Percentage
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 0 | 0 | 0 |
Reserves ReservesCr | 0 | 1 | 5 |
| 2 | 3 | 4 | |
| 1 | 1 | 2 | |
| 4 | 5 | 11 | |
| 3 | 3 | 9 | |
| 1 | 1 | 2 | |
| 4 | 5 | 11 |
Cash Flow
Standalone
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| 1 | 0 | -2 | |
| 0 | 0 | -1 | |
| -1 | 0 | 3 | |
Net Cash Flow Net Cash FlowCr | 0 | 0 | 0 |
Free Cash Flow Free Cash FlowCr | 1 | 0 | -3 |
CFO To PAT CFO To PAT% | 242.8 | 28.0 | -84.7 |
CFO To EBITDA CFO To EBITDA% | 109.6 | 18.8 | -59.4 |
Ratios
Standalone
| Financial Year | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
Market Cap Market CapitalizationCr | 0 | 0 | 0 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 |
EV To EBITDA EV To EBITDA | 3.0 | 1.7 | 1.0 |
GPM GPM% | 41.5 | 42.7 | 34.0 |
OPM OPM% | 21.4 | 24.4 | 23.3 |
NPM NPM% | 9.7 | 16.4 | 16.3 |
ROCE ROCE% | 21.4 | 35.4 | 38.4 |
ROE ROE% | 106.7 | 75.8 | 48.9 |
ROA ROA% | 6.9 | 17.7 | 24.1 |